// App-Quantinova.ai

WP58 : Early Recanalization Rates Do Not Differ among Stroke Subtypes when Treated with Argatroban and Intravenous tPA: A Subanalysis of the Argatroban TPA Stroke Study

Researchers

Presenter

  • Waldo R Guerrero

Principal Investigators

  • Andrei V Alexandrov

  • Sean I Savitz

  • Nicole R Gonzales

  • Tzu-Ching Wu

  • Mohammad H Rahbar

  • Georgios Tsivgoulis

  • Andrew M Demchuk

  • James C Grotta

  • Patrick D. Lyden

  • Yazan J Alderazi

  • Jessica Lee

  • Sheryl Martin-Schild

  • Loren Shen

  • April Sisson

  • Clotilde Balucani

  • Hui Peng

Medical Centers

  • University of Alabama at Birmingham, Birmingham, AL

  • Democritus University of Thrace, Alexandroupoli, Greece

  • Tulane Univ Medical Ctr, Houston, LA

  • University of Miami, Miami, FL

  • University of Houston, Houston, TX

  • SUNY Downstate, New York, NY

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • The University of Texas Southwestern, Dallas, TX

  • Univ of Calgary, Calgary, Canada

Locations

  • United States

  • Canada

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

  • Diabetes

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Argatroban

  • Evithrom

Outcome

  • N/A

Study Design

  • open label

  • randomized

Phase

  • NA

Study Id's

  • NCT00268762

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved